Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ASKG315 as a Single Agent and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors
Day, Daphne
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
6/12/22
→
5/12/27
View all
View less